Relay Therapeutics
Dec 27, 2018
Vedanta raises; Relay Therapeutics reels in; Gene therapy for SMA
Vedanta raises USD 27 Million to move microbiome assets through the clinic Vedanta Biosciences raises USD 27 million in its series C round. The cash will bolster its microbiome-derived drugs pipeline. The capital will aid a phase 1/2 trial of VE416 in food allergy, a phase 2 study of VE303 in recurrent...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
